109 related articles for article (PubMed ID: 15753389)
1. Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells.
Tang W; Li Y; Yu D; Thomas-Tikhonenko A; Spiegelman VS; Fuchs SY
Cancer Res; 2005 Mar; 65(5):1904-8. PubMed ID: 15753389
[TBL] [Abstract][Full Text] [Related]
2. The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer.
Fuchs SY; Spiegelman VS; Kumar KG
Oncogene; 2004 Mar; 23(11):2028-36. PubMed ID: 15021890
[TBL] [Abstract][Full Text] [Related]
3. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer.
Ougolkov A; Zhang B; Yamashita K; Bilim V; Mai M; Fuchs SY; Minamoto T
J Natl Cancer Inst; 2004 Aug; 96(15):1161-70. PubMed ID: 15292388
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-specific protease USP47 is a novel beta-TRCP interactor regulating cell survival.
Peschiaroli A; Skaar JR; Pagano M; Melino G
Oncogene; 2010 Mar; 29(9):1384-93. PubMed ID: 19966869
[TBL] [Abstract][Full Text] [Related]
5. A 2-Benzylmalonate Derivative as STAT3 Inhibitor Suppresses Tumor Growth in Hepatocellular Carcinoma by Upregulating β-TrCP E3 Ubiquitin Ligase.
Peng T; Wonganan O; Zhang Z; Yu J; Xi R; Cao Y; Suksamrarn A; Zhang G; Wang F
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805945
[TBL] [Abstract][Full Text] [Related]
6. A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice.
Sharma R; Williams PJ; Gupta A; McCluskey B; Bhaskaran S; Muñoz S; Oyajobi BO
Oncotarget; 2015 Aug; 6(25):21589-602. PubMed ID: 26009993
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 suppresses cellular accumulation of β-TrCP E3 ligase via protein degradation.
Woo SR; Byun JG; Kim YH; Park ER; Joo HY; Yun M; Shin HJ; Kim SH; Shen YN; Park JE; Park GH; Lee KH
Biochem Biophys Res Commun; 2013 Nov; 441(4):831-7. PubMed ID: 24211209
[TBL] [Abstract][Full Text] [Related]
9. SCF
Ci Y; Li X; Chen M; Zhong J; North BJ; Inuzuka H; He X; Li Y; Guo J; Dai X
Protein Cell; 2018 Oct; 9(10):879-889. PubMed ID: 29497989
[TBL] [Abstract][Full Text] [Related]
10. β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H.
Cheng Y; Gao WW; Tang HM; Deng JJ; Wong CM; Chan CP; Jin DY
Sci Rep; 2016 Mar; 6():23938. PubMed ID: 27029215
[TBL] [Abstract][Full Text] [Related]
11. β-TrCP-dependent degradation of ASK1 suppresses the induction of the apoptotic response by oxidative stress.
Cheng R; Takeda K; Naguro I; Hatta T; Iemura SI; Natsume T; Ichijo H; Hattori K
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2271-2280. PubMed ID: 30031111
[TBL] [Abstract][Full Text] [Related]
12. Ribosomal protein S27-like regulates autophagy via the β-TrCP-DEPTOR-mTORC1 axis.
Xiong X; Liu X; Li H; He H; Sun Y; Zhao Y
Cell Death Dis; 2018 Nov; 9(11):1131. PubMed ID: 30425236
[TBL] [Abstract][Full Text] [Related]
13. β-TrCP upregulates HIF-1 in prostate cancer cells.
Cohen M; Amir S; Golan M; Ben-Neriah Y; Mabjeesh NJ
Prostate; 2019 Mar; 79(4):403-413. PubMed ID: 30488478
[TBL] [Abstract][Full Text] [Related]
14. Role of β-TrCP ubiquitin ligase receptor in UVB mediated responses in skin.
Bhatia N; Demmer TA; Sharma AK; Elcheva I; Spiegelman VS
Arch Biochem Biophys; 2011 Apr; 508(2):178-84. PubMed ID: 21187057
[TBL] [Abstract][Full Text] [Related]
15. Revealing β-TrCP activity dynamics in live cells with a genetically encoded biosensor.
Paul D; Kales SC; Cornwell JA; Afifi MM; Rai G; Zakharov A; Simeonov A; Cappell SD
Nat Commun; 2022 Oct; 13(1):6364. PubMed ID: 36289220
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase USP33 is negatively regulated by β-TrCP through ubiquitin-dependent proteolysis.
Cheng Q; Yuan Y; Li L; Guo T; Miao Y; Ren Y; Liu J; Feng Q; Wang X; Zhao P; Zuo Y; Qian L; Zhang L; Zheng H
Exp Cell Res; 2017 Jul; 356(1):1-7. PubMed ID: 28506875
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the discs large tumor suppressor by a phosphorylation-dependent interaction with the beta-TrCP ubiquitin ligase receptor.
Mantovani F; Banks L
J Biol Chem; 2003 Oct; 278(43):42477-86. PubMed ID: 12902344
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin E3 ligase β-TrCP negatively regulates surface protein of hepatitis B virus.
Tu W; Liu J; Qian F; Zhu L; Li M; Zheng H; Zhu C
J Med Virol; 2023 Mar; 95(3):e28620. PubMed ID: 36846904
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer.
Bromberg KD; Kluger HM; Delaunay A; Abbas S; DiVito KA; Krajewski S; Ronai Z
Cancer Res; 2007 Sep; 67(17):8172-9. PubMed ID: 17804730
[TBL] [Abstract][Full Text] [Related]
20. SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.
Tan M; Gallegos JR; Gu Q; Huang Y; Li J; Jin Y; Lu H; Sun Y
Neoplasia; 2006 Dec; 8(12):1042-54. PubMed ID: 17217622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
